Head of Global Regulatory Asset Policy

Takeda•Boston, MA

6d•$212,000 - $333,190

About The Position

The Head of Global Regulatory Asset Policy leads GRPI’s global asset-facing regulatory policy capability, expanding the US asset policy model into a cohesive global capability that provides dedicated policy support to development programs while preserving deep regional expertise. The role owns the strategy, operating model, priorities, standards, and performance of the capability and provides senior policy leadership to therapeutic area units, Global Regulatory Leads, regulatory strategists, and product teams on consequential asset and portfolio issues. The role deploys asset policy expertise according to portfolio needs, development milestones, risk, and potential enterprise impact. It maintains deep US regulatory policy expertise while building strong EU and broader global capability, and connects asset challenges with regulatory precedent, intelligence, legislation, pilots, external engagement, and advocacy opportunities. The position partners with regional policy leads to ensure asset strategies reflect local health authority expectations and implementation realities. In close partnership with the Head of Global R&D Policy, the role integrates asset and enterprise policy by identifying recurring asset barriers, emerging precedents, and cross-portfolio opportunities; determining when these call for broader Takeda positions or policy action; and shaping coordinated policy, advocacy, and external engagement strategies. The role also establishes intake, prioritization, assignment, quality, impact-measurement, and closure standards, and coaches and develops the asset policy team.

Requirements

10+ years of progressively responsible experience with substantial leadership of complex regulatory policy, regulatory strategy, or asset-facing external engagement.
Deep expertise in global drug development and regulatory strategy.
Demonstrated success applying policy and precedent to asset decisions across programs or therapeutic areas.
Strong strategic judgment and ability to translate complex scientific, regulatory, legislative, or policy issues into clear recommendations for the intended audience.
Demonstrated ability to work across regions and functions, influence without authority, and maintain momentum in a matrixed organization.
Excellent written and verbal communication skills and sound judgment in external engagement.
Demonstrates Takeda Leadership Behaviors: Think Strategically, Inspire Others, Deliver Priorities, and Elevate Capabilities.

Responsibilities

Own the strategy, operating model, priorities, standards, and performance of Global Regulatory Asset Policy.
Provide senior policy leadership to therapeutic area units, Global Regulatory Leads, regulatory strategists, and product teams on consequential asset and portfolio issues.
Deploy asset policy expertise according to portfolio need, development milestones, risk, and potential enterprise impact.
Maintain deep US regulatory policy expertise and build strong EU and broader global capability, deploying expertise according to portfolio needs and development priorities.
Connect asset challenges with regulatory precedent, intelligence, legislation, pilots, external engagement, and advocacy opportunities.
Partner with regional policy leads so asset strategies reflect local health authority expectations and implementation realities.
Partner with the Head of Global R&D Policy to integrate asset and enterprise policy, identify recurring asset barriers, emerging precedents, and cross-portfolio opportunities, and determine when broader Takeda positions or policy action are needed.
Jointly shape coordinated policy, advocacy, and external engagement strategies with the Head of Global R&D Policy.
Establish intake, prioritization, assignment, quality, impact-measurement, and closure standards.
Coach and develop the asset policy team.